Advertisement
In This Section
Issues & Advocacy
SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
LATEST NEWS
- July 10, 2020 —
SNMMI Hosts FDA Townhall on the Impact of COVID-19
On Wednesday, June 17th, SNMMI hosted an FDA Townhall on the Impact of COVID-19 on regulatory activities. - June 18, 2020 —
SNMMI and Coalition Partners Embrace Virtual Fly-Ins
Beginning in June, SNMMI and our Appropriate Payment Coalition Partners, the Medical Imaging Technology Alliance (MITA) and the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR) renewed their efforts to continue promoting H.R. 3772, the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019. - June 11, 2020 —
SNMMI Requests Regulatory Relief for Training for Imaging and Localization Studies
Today, SNMMI along with ASNC, ASTRO and ACR requested regulatory relief for Training for imaging and localization studies during the COVID-19 Public Health Emergency. - June 1, 2020 —
USP Announces New Implementation Date for USP General Chapter <825>
The United States Pharmacopeial Convention (USP) has updated the implementation date for General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging to December 1, 2020. - May 19, 2020 —
Recent HHS Updates During the COVID-19 Pandemic
As we wait the enactment of a fourth stimulus package, SNMMI would like to inform its membership of the recent U.S. Department of Health and Human Services (HHS) administrative updates as a result of COVID-19. - May 18, 2020 —
SNMMI Selects Two Henkin Fellows for 2020
Each year, the Robert E. Henkin Fellowship awards the opportunity for an early career professional to visit Washington, DC, and receive direct personal exposure to government relations activities of the SNMMI. SNMMI is pleased to announce that Domnique Newallo, MD, RT (R),(CT), and Justin Peacock, MD, PhD, have been selected as our 2020 Robert E. Henkin Government Relations Fellows. - May 15, 2020 —
SNMMI Advocates for Access to Diagnostic Radiopharmaceuticals through COVID-19 and Beyond
This week SNMMI and its coalition partners sent a letter imploring Congress to take immediate action to ensure patient access to FDA-approved diagnostic radiopharmaceutical drugs that aid in the detection of cancer, cardiovascular conditions and neurological disorders. - May 8, 2020 —
SNMMI Advocates for Frontline Healthcare Workers
SNMMI joined various other medical professional societies in advocating for all frontline members of the healthcare delivery system during the COVID-19 pandemic
Click For More Government Relations News